Profil
Jacob Uittenbogaard formerly worked at EffRx, Inc., as Director in 2011, EffRx Pharmaceuticals SA, as Director, R.J.
Reynolds International BV (Hilversum), as Chief Financial Officer from 1973 to 2000, and Jupiter Neurosciences, Inc., as Chief Financial Officer, Secretary & Treasurer from 2016 to 2021.
Anciens postes connus de Jacob Uittenbogaard
| Sociétés | Poste | Fin |
|---|---|---|
| JUPITER NEUROSCIENCES, INC. | Directeur Financier/CFO | 31/05/2021 |
EffRx, Inc.
 EffRx, Inc. Pharmaceuticals: MajorHealth Technology EffRx Inc. is an innovative company that exploits drug delivery technologies to improve the efficacy and tolerability of existing approved compounds with a focus on drugs, with high commercial potential and once developed partner these products with established pharmaceutical companies. Their goal is to become a global provider of products, based on alternative drug delivery technologies for both the prescription and OTC markets, by applying their technologies to well established proven compounds and developing reformulated products with reduced gastrointestinal side effects, better absorption and faster onset of action. Thereby generating better products for patients in a cost effective manner. The primary focus and the leading project is to introduce EX101 (a proprietary effervescent alendronate) in markets worldwide, capitalizing on the unique intellectual property position of the combined EffRx patents and the patents exclusively licensed from Merck & Co. | Directeur Financier/CFO | 04/01/2011 |
R.J. Reynolds International BV (Hilversum)
 R.J. Reynolds International BV (Hilversum) TobaccoConsumer Non-Durables R.J. Reynolds International BV (Hilversum) manufactures tobacco and related products. The company is headquartered in Geneva, Switzerland. | Directeur Financier/CFO | 01/12/2000 |
EffRx Pharmaceuticals SA
 EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
EffRx, Inc.
EffRx, Inc. Pharmaceuticals: MajorHealth Technology EffRx Inc. is an innovative company that exploits drug delivery technologies to improve the efficacy and tolerability of existing approved compounds with a focus on drugs, with high commercial potential and once developed partner these products with established pharmaceutical companies. Their goal is to become a global provider of products, based on alternative drug delivery technologies for both the prescription and OTC markets, by applying their technologies to well established proven compounds and developing reformulated products with reduced gastrointestinal side effects, better absorption and faster onset of action. Thereby generating better products for patients in a cost effective manner. The primary focus and the leading project is to introduce EX101 (a proprietary effervescent alendronate) in markets worldwide, capitalizing on the unique intellectual property position of the combined EffRx patents and the patents exclusively licensed from Merck & Co. | Health Technology |
EffRx Pharmaceuticals SA
EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Health Technology |
R.J. Reynolds International BV (Hilversum)
R.J. Reynolds International BV (Hilversum) TobaccoConsumer Non-Durables R.J. Reynolds International BV (Hilversum) manufactures tobacco and related products. The company is headquartered in Geneva, Switzerland. | Consumer Non-Durables |
Jupiter Neurosciences, Inc.
 Jupiter Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company. Its therapeutic candidate, JOTROL is applicable to many central nervous system diseases, including Alzheimer’s disease and traumatic brain injury. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in June 2015 and is headquartered in Jupiter, FL. | Health Technology |
